RJF Stock Overview
A pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for RJF from our risk checks.
Laboratorio Reig Jofre, S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €3.20 |
52 Week High | €3.28 |
52 Week Low | €2.15 |
Beta | 0.88 |
1 Month Change | 25.98% |
3 Month Change | 28.51% |
1 Year Change | 25.98% |
3 Year Change | -38.34% |
5 Year Change | 40.97% |
Change since IPO | -16.23% |
Recent News & Updates
Recent updates
These 4 Measures Indicate That Laboratorio Reig Jofre (BME:RJF) Is Using Debt Extensively
Feb 02This Analyst Just Downgraded Their Laboratorio Reig Jofre, S.A. (BME:RJF) EPS Forecasts
Mar 07We Think Laboratorio Reig Jofre (BME:RJF) Is Taking Some Risk With Its Debt
Mar 07Laboratorio Reig Jofre (BME:RJF) Seems To Use Debt Quite Sensibly
May 17The Laboratorio Reig Jofre (BME:RJF) Share Price Has Gained 146%, So Why Not Pay It Some Attention?
Mar 07Is Laboratorio Reig Jofre (BME:RJF) Using Too Much Debt?
Jan 14Laboratorio Reig Jofre (BME:RJF) Shareholders Booked A 47% Gain In The Last Year
Dec 05Shareholder Returns
RJF | ES Pharmaceuticals | ES Market | |
---|---|---|---|
7D | 15.9% | -1.8% | -0.2% |
1Y | 26.0% | 14.7% | 19.0% |
Return vs Industry: RJF matched the Spanish Pharmaceuticals industry which returned 14.7% over the past year.
Return vs Market: RJF underperformed the Spanish Market which returned 19% over the past year.
Price Volatility
RJF volatility | |
---|---|
RJF Average Weekly Movement | 5.1% |
Pharmaceuticals Industry Average Movement | 3.6% |
Market Average Movement | 3.2% |
10% most volatile stocks in ES Market | 7.0% |
10% least volatile stocks in ES Market | 1.2% |
Stable Share Price: RJF has not had significant price volatility in the past 3 months.
Volatility Over Time: RJF's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1929 | 1,331 | Ignasi Reig | www.reigjofre.com |
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers medical devices, cosmetics, parapharmacy, and animal food related products; and biotechnological and health products. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, joint health and pain, women’s health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand.
Laboratorio Reig Jofre, S.A. Fundamentals Summary
RJF fundamental statistics | |
---|---|
Market cap | €252.16m |
Earnings (TTM) | €8.85m |
Revenue (TTM) | €325.74m |
28.5x
P/E Ratio0.8x
P/S RatioIs RJF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RJF income statement (TTM) | |
---|---|
Revenue | €325.74m |
Cost of Revenue | €145.12m |
Gross Profit | €180.63m |
Other Expenses | €171.78m |
Earnings | €8.85m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 30, 2024
Earnings per share (EPS) | 0.11 |
Gross Margin | 55.45% |
Net Profit Margin | 2.72% |
Debt/Equity Ratio | 21.8% |
How did RJF perform over the long term?
See historical performance and comparison